Detalhe da pesquisa
1.
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.
Eur J Haematol
; 102(1): 79-86, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30267597